Bedford, MA, United States of America

Steven Bittenson

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Thermo Power Corporation. Active years: 2000.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Steven Bittenson

Introduction

Steven Bittenson is an accomplished inventor based in Bedford, MA (US). He has made significant contributions to the field of chemical engineering, particularly in the area of plasma technology. His work focuses on the preparation and delivery of highly reactive chemical species, which has potential applications in various industries.

Latest Patents

Bittenson holds a patent for the "Preparation of independently generated highly reactive chemical species." This invention involves a method and apparatus for the delivery of exogenous non-thermal plasma activated species to a subject fluid. His innovative approach has the potential to enhance various chemical processes.

Career Highlights

Steven Bittenson is associated with Thermo Power Corporation, where he continues to develop and refine his inventions. His expertise in plasma technology has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Bittenson has collaborated with notable colleagues, including Frederick E Becker and Ronald W Breault. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Steven Bittenson's contributions to the field of chemical engineering and plasma technology exemplify the spirit of innovation. His patent and ongoing work at Thermo Power Corporation highlight his commitment to advancing scientific knowledge and practical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…